284 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CHRM1Cholinergic receptor, muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CHRM2Cholinergic receptor, muscarinic 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM3Cholinergic receptor, muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
CHRM4Cholinergic receptor, muscarinic 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM5Cholinergic receptor, muscarinic 5FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
CHRNA3Cholinergic receptor, nicotinic, alpha 3 (neuronal)FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
CHRNA4Cholinergic receptor, nicotinic, alpha 4 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA7Cholinergic receptor, nicotinic, alpha 7 (neuronal)FDA approved drug targets
Predicted membrane proteins
Transporters
Mixed
CLCN2Chloride channel, voltage-sensitive 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
CNR1Cannabinoid receptor 1 (brain)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CNR2Cannabinoid receptor 2 (macrophage)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
COMTCatechol-O-methyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CPT1ACarnitine palmitoyltransferase 1A (liver)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CSF2RAColony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CSF2RBColony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CSF3RColony stimulating factor 3 receptor (granulocyte)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CYP19A1Cytochrome P450, family 19, subfamily A, polypeptide 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
CYP51A1Cytochrome P450, family 51, subfamily A, polypeptide 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CYSLTR1Cysteinyl leukotriene receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
CYSLTR2Cysteinyl leukotriene receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
DHODHDihydroorotate dehydrogenase (quinone)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
DRD1Dopamine receptor D1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
DRD2Dopamine receptor D2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
DRD5Dopamine receptor D5Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
EDNRAEndothelin receptor type AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
EDNRBEndothelin receptor type BDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
EGFEpidermal growth factorCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Group enriched
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
EPHA2EPH receptor A2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
ERBB2V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
ERBB4V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
FADS1Fatty acid desaturase 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FADS2Fatty acid desaturase 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FCER1AFc fragment of IgE, high affinity I, receptor for; alpha polypeptideFDA approved drug targets
Predicted membrane proteins
Mixed
FCER1GFc fragment of IgE, high affinity I, receptor for; gamma polypeptideFDA approved drug targets
Predicted membrane proteins
Expressed in all
FCGR2AFc fragment of IgG, low affinity IIa, receptor (CD32)CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
FCGR2BFc fragment of IgG, low affinity IIb, receptor (CD32)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
FCGR3AFc fragment of IgG, low affinity IIIa, receptor (CD16a)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FGFR1Fibroblast growth factor receptor 1Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FKBP1AFK506 binding protein 1A, 12kDaEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FLT3Fms-related tyrosine kinase 3Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
FLT4Fms-related tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FOLH1Folate hydrolase (prostate-specific membrane antigen) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
FXYD2FXYD domain containing ion transport regulator 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
GABBR1Gamma-aminobutyric acid (GABA) B receptor, 1FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
GABRA1Gamma-aminobutyric acid (GABA) A receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched

« prev | Page of 6 | next »